<p style="text-align: justify;">The Biotechnology Havana 2010 Congress opens in this capital on Wednesday with 130 experts from 27 countries, and is focused on comprehensive care for diabetic foot ulcer patients. That condition is mostly treated in Cuba with Heberprot-P, a medicine created by the Genetic Engineering and Biotechnology Center, which sponsors the congress. Four years after it was launched onto the market, the results of post-commercialization studies of that medicine will be discussed by roundtables, seminars, and workshops at the congress, which concludes on Friday.
Read More